Top Heal Care Stocks To Own For 2019

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1129099955&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1129099955/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Hacking and criminal concept. A hacker in a secret hiding place surrounded by neon lights. (Photocredit: Getty).

&a;nbsp;

A Greek maxim goes that there are three things one should be afraid of, namely &a;ldquo;Fire, woman and the sea&a;rdquo; (&l;em&g;&a;Pi;&a;#8166;&a;rho;, &a;gamma;&a;upsilon;&a;nu;&a;#8052; &a;kappa;&a;alpha;&a;#8054; &a;theta;&a;#940;&a;lambda;&a;alpha;&a;sigma;&a;sigma;&a;alpha;)&l;/em&g;. Well, the cyber version might go something along the lines&a;nbsp;that cybercrime and data breaches are &a;ldquo;more devastating&a;rdquo; and detrimental to small- and medium-sized businesses (SMBs) in the United States (U.S.) than&a;nbsp;natural disasters – fire, floods and transit strikes – combined.

But however you slice it and dice the numbers on the financial impact of cyberattacks, it doesn&s;t make for pretty reading.

Top Heal Care Stocks To Own For 2019: Avino Silver(ASM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Bard Associates Inc. increased its position in shares of Avino Silver & Gold Mines Ltd (NYSEAMERICAN:ASM) by 41.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,595,700 shares of the basic materials company’s stock after buying an additional 466,250 shares during the period. Bard Associates Inc. owned 3.02% of Avino Silver & Gold Mines worth $1,979,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Avino Silver & Gold Mines (ASM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Own For 2019: NGL ENERGY PARTNERS LP(NGL)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NGL Energy Partners (NGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NGL Energy Partners (NGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Own For 2019: BlackRock New Jersey Municipal Income Trust(BNJ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Blackrock New Jersey Municipal Income Tr (NYSE:BNJ) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Blackrock New Jersey Municipal Income Tr earned a news impact score of 0.36 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 48.5554072096128 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

  • [By Max Byerly]

    News headlines about Blackrock New Jersey Municipal Income Tr (NYSE:BNJ) have been trending positive on Wednesday, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Blackrock New Jersey Municipal Income Tr earned a news impact score of 0.32 on Accern’s scale. Accern also gave media coverage about the investment management company an impact score of 47.9578208138909 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top Heal Care Stocks To Own For 2019: Mastech Holdings, Inc(MHH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Mastech Digital Inc (NYSEAMERICAN:MHH) CFO John J. Cronin sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $10.74, for a total value of $128,880.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Leave a Reply

Your email address will not be published. Required fields are marked *